Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002863 · ClinicalTrials.gov registry record · Phase 1
Cryosurgery in Treating Patients With Soft Tissue Sarcoma
A Phase 1 study, sponsored by University of Southern California.
- Terminated
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT00002863 is a Phase 1 study that was terminated before completion, run by University of Southern California. The registered enrollment target is 19 participants.
The verdict
NCT00002863, a Phase 1 study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
RATIONALE: Cryosurgery kills cancer cells by freezing them. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining cryosurgery with chemotherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of cryosurgery with or without chemotherapy in treating patients who have soft tissue sarcoma.
Interventions
- PROCEDURE conventional surgery
- DRUG chemotherapy
- PROCEDURE cryosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 1996-06 |
| Est. Completion | 2000-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002863
The ClinicalTrials.gov registry entry for NCT00002863 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which conventional surgery is the first listed.
NCT00002863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002863 about?
NCT00002863 is a clinical study titled "Cryosurgery in Treating Patients With Soft Tissue Sarcoma". RATIONALE: Cryosurgery kills cancer cells by freezing them. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining cryosurgery with chemotherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of cryosurger...
What is the current status of trial NCT00002863?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 1996-06. Estimated completion is 2000-07.
What interventions are being tested in trial NCT00002863?
The interventions under investigation include: conventional surgery (PROCEDURE), chemotherapy (DRUG), cryosurgery (PROCEDURE).
Who is sponsoring clinical trial NCT00002863?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.